Coherus Oncology Inc (CHRS)

Revenue

$50.94M

TTM · Period ending: · USD

CHRS logo

CHRS Revenue

Latest reported$50.94M
CHRS TTM Revenue ($2.75M → $50.94M)
High-resolution chart · PNG

CHRS revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Revenue — Trailing twelve months (TTM) (USD)
Period endingRevenue (USD)
50,936,000
46,883,000
42,172,000
83,568,000
142,771,000
197,496,000
192,205,000
229,585,000
233,379,000
227,116,000
257,244,000
211,072,000
181,928,000
183,363,000
211,042,000
239,061,000
276,140,000
303,632,000
326,551,000
363,599,000
394,647,000
442,678,000
475,824,000
489,261,000
487,394,000
435,153,000
356,071,000
232,215,000
120,531,000
37,098,000
0
0
0
1,395,000
1,556,000
2,400,000
165,235,000
177,908,000
190,106,000
199,460,000
43,792,000
36,590,000
30,041,000
26,336,000
35,221,000
33,320,000
31,106,000
25,845,000
10,299,000
5,841,000
2,751,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.